Marc Becker
2018 - Concert Pharmaceuticals
In 2018, Marc Becker earned a total compensation of $2.5M as Chief Financial Officer at Concert Pharmaceuticals.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Non-Equity Incentive Plan | $155,040 |
| Option Awards | $1,880,930 |
| Salary | $375,682 |
| Other | $8,880 |
| Total | $2,450,532 |
Becker received $1.9M in option awards, accounting for 77% of the total pay in 2018.
Becker also received $30K in bonus, $155K in non-equity incentive plan, $375.7K in salary and $8.9K in other compensation.
Rankings
In 2018, Marc Becker's compensation ranked 4,749th out of 14,244 executives tracked by ExecPay. In other words, Becker earned more than 66.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,749 out of 14,244 | 67th |
Division Manufacturing | 1,786 out of 5,765 | 69th |
Major group Chemicals And Allied Products | 646 out of 2,128 | 70th |
Industry group Drugs | 543 out of 1,817 | 70th |
Industry Pharmaceutical Preparations | 419 out of 1,391 | 70th |
Source: SEC filing on April 29, 2019.
Becker's colleagues
We found two more compensation records of executives who worked with Marc Becker at Concert Pharmaceuticals in 2018.